Economic evaluation of meningococcal serogroup B childhood vaccination in Ontario, Canada (Q42201516)

18 October 2017

title

Economic evaluation of meningococcal serogroup B childhood vaccination in Ontario, Canada (English)

1 reference

18 October 2017

0 references

9

1 reference

18 October 2017

Beate Sander

10

0 references

Natasha Sarah Crowcroft

5

object named as

Natasha Crowcroft

1 reference

18 October 2017

2

Shelley L Deeks

1 reference

18 October 2017

7

Jeffrey C Kwong

1 reference

18 October 2017

4

Lisa Strifler

1 reference

18 October 2017

Hong Anh T Tu

1

1 reference

18 October 2017

Shaun K Morris

3

1 reference

18 October 2017

Frances B Jamieson

6

1 reference

18 October 2017

Peter C Coyte

8

1 reference

18 October 2017

language of work or name

English

0 references

publication date

12 August 2014

1 reference

18 October 2017

1 reference

18 October 2017

volume

32

1 reference

18 October 2017

issue

42

1 reference

18 October 2017

page(s)

5436-5446

1 reference

The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease.

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2014.07.096

The changing and dynamic epidemiology of meningococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2014.07.096

Epidemiology of serogroup B invasive meningococcal disease in Ontario, Canada, 2000 to 2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2014.07.096

Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2014.07.096

Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2014.07.096

Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2014.07.096

Cost-effectiveness of vaccination against meningococcal B among Dutch infants: Crucial impact of changes in incidence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2014.07.096

Introducing vaccination against serogroup B meningococcal disease: an economic and mathematical modelling study of potential impact

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2014.07.096

WHO Guide for standardisation of economic evaluations of immunization programmes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2014.07.096

State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2014.07.096

Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2014.07.096

Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2014.07.096

Improving decision analyses: parent preferences (utility values) for pediatric health outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2014.07.096

Parents' preferences for outcomes associated with childhood vaccinations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2014.07.096

Utility scores for chronic conditions in a community-dwelling population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2014.07.096

Assessing health-related quality-of-life changes in informal caregivers: an evaluation in parents of children with major congenital anomalies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2014.07.096

Patterns and costs of health care use of children with medical complexity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2014.07.096

Herd immunity and herd effect: new insights and definitions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2014.07.096

Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2014.07.096

10.1016/J.VACCINE.2014.07.096

7 January 2021

Identifiers

DOI

1 reference

18 October 2017

1 reference